Combo Semaglutide-Amylin Analogue Boosts Weight Loss Regardless of Diabetes

By News Health
6 hours Ago

(MedPage Today) — CHICAGO — Adding investigational cagrilintide to a GLP-1 receptor agonist increased weight loss in adults with obesity with or without type 2 diabetes, a pair of phase IIIa trials found.
In REDEFINE 1, which included 3,417…

Source link : https://www.medpagetoday.com/meetingcoverage/ada/116188

Author :

Publish date : 2025-06-22 19:09:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Mounjaro weight loss jab available at GPs

Once-Weekly Efsitora Noninferior to Daily Insulin in T2D

'5 Years, 10 Years at Most, I'm Going to Retire': What We Heard This Week

Once-Weekly Basal Insulin Non-Inferior to Several Daily Options in Type 2 Diabetes

Can Behavioral Support Enhance CGM Use in T1D?

Fewer ECG Abnormalities in Early T2D With Combo Therapy